Evidence map›Paper›PMID 24277511›Full record

ArticleLa Radiologia medica2014

PET-CT in oncological patients: analysis of informal care costs in cost-benefit assessment.

Antonio Orlacchio, Anna Micaela Ciarrapico, Orazio Schillaci, Fabrizio Chegai, Daniela Tosti, Fabrizio D'Alba, Manlio Guazzaroni, Giovanni Simonetti

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Radiolabeled PET/MRI Nanoparticles for Tumor Imaging.Journal of clinical medicine · 2019
    Review
  3. Review
  4. Usefulness of esophagogastroduodenoscopy andOral and maxillofacial surgery · 2017
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Antonio OrlacchioDepartment of Diagnostic and Molecular Imaging, Interventional Radiology, Nuclear Medicine and Radiation Therapy, University Hospital "Tor Vergata", Viale Oxford 81, 00133, Rome, Italy, aorlacchio@uniroma2.it.
Anna Micaela Ciarrapico
Orazio Schillaci
Fabrizio Chegai
Daniela Tosti
Fabrizio D'Alba
Manlio Guazzaroni
Giovanni Simonetti
University of Rome Tor Vergata · ITPoliclinico Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe authors analysed the impact of nonmedical costs (travel, loss of productivity) in an economic analysis of PET-CT (positron-emission tomography-computed tomography) performed with standard contrast-enhanced CT protocols (CECT). MATERIALS AND

methodsFrom October to November 2009, a total of 100 patients referred to our institute were administered a questionnaire to evaluate the nonmedical costs of PET-CT. In addition, the medical costs (equipment maintenance and depreciation, consumables and staff) related to PET-CT performed with CECT and PET-CT with low-dose nonenhanced CT and separate CECT were also estimated.

resultsThe medical costs were 919.3 euro for PET-CT with separate CECT, and 801.3 euro for PET-CT with CECT. Therefore, savings of approximately 13% are possible. Moreover, savings in nonmedical costs can be achieved by reducing the number of hospital visits required by patients undergoing diagnostic imaging.

conclusionsNonmedical costs heavily affect patients' finances as well as having an indirect impact on national health expenditure. Our results show that PET-CT performed with standard dose CECT in a single session provides benefits in terms of both medical and nonmedical costs.

Indexed as

Costs and Cost AnalysisContrast MediaCost-Benefit AnalysisEfficiencyFemaleFluorodeoxyglucose F18HumansItalyMaleMiddle AgedMultimodal ImagingPositron-Emission TomographyRadiopharmaceuticalsSurveys and QuestionnairesTomography, X-Ray ComputedTravelContrast MediaFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID24277511
OpenAlexW1992220726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.